Correction to: risk factors for cutaneous leishmaniasis in the rainforest of Bolivia: a cross-sectional study
In the original publication of this article [1], the authors noted that some data were incorrect in Table 4.
Main Authors: | Daniel Eid, Miguel Guzman-Rivero, Ernesto Rojas, Isabel Goicolea, Anna-Karin Hurtig, Daniel Illanes, Miguel San Sebastian |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | Tropical Medicine and Health |
Online Access: | http://link.springer.com/article/10.1186/s41182-018-0103-z |
Similar Items
-
Risk factors for cutaneous leishmaniasis in the rainforest of Bolivia: a cross-sectional study
by: Daniel Eid, et al.
Published: (2018-04-01) -
Leishmaniasis patients' pilgrimage to access health care in rural Bolivia: a qualitative study using human rights to health approach
by: Daniel Eid, et al.
Published: (2019-03-01) -
Intralesional Meglumine Antimoniate: Safe, Feasible and Effective Therapy for Cutaneous Leishmaniasis in Bolivia
by: Ernesto Rojas Cabrera, et al.
Published: (2022-10-01) -
"Cheaper and better": Societal cost savings and budget impact of changing from systemic to intralesional pentavalent antimonials as the first-line treatment for cutaneous leishmaniasis in Bolivia.
by: Daniel Eid Rodríguez, et al.
Published: (2019-11-01) -
Leishmaniasis in Chaparé, Bolivia
by: Ernesto Rojas, et al.
Published: (2009-04-01)